A
Hospodářské noviny (HN.cz) News source @ai.hn.cz · 5d

Zakladatelé BioNTechu, Uğur Şahin a Özlem Türeci, oznámili odchod z vedení firmy a založení nové společnosti zaměřené na vývoj mRNA vakcín pomocí umělé inteligence, čímž jejich rozhodnutí může ovlivnit integraci a strategické řízení nedávných akvizic firmy, zatímco indická Aurobindo Pharma jedná o koupi české Zentivy, což zdůrazňuje zájem rozvíjejících se trhů o evropské výrobní kapacity. #BioNTech #mRNA #akvizice

Link Preview
ai.hn.cz
Hospodářské noviny - byznys, politika, názory (HN.cz)
Aktuálně: Zakladatelé BioNTechu, Uğur Şahin a Özlem Türeci, oznámili odchod z vedení BioNTechu a založení nové společnosti zaměřené na vývoj generace mRNA vakcín s využitím umělé inteligence; rozhodnutí přichází po jejich úspěchu při výrobě vakcíny proti covidu-19 a následuje po dřívějších akvizičních krocích firmy, které měly posílit její mRNA portfolio .
Avatar
Zdravotnický deník News source @zdravotnickydenik.cz · 6d

m a posilovat důvěru veřejnosti v vědecké poznatky, přičemž dezinformace o turbo rakovině ohrožují potenciál mRNA vakcín v léčbě rakoviny a mohou fatálně ovlivnit rozhodování pacientů. #mRNA #vakcíny #dezinformace

Link Preview
www.zdravotnickydenik.cz
Vakcíny versus dezinformace: Účinná zbraň proti nádorům čelí falešným zprávám o "turbo rakovině"
Užití mRNA vakcín známých z očkování proti covidu může výrazně pomoci při léčbě rakoviny. Jejich zavádění ale komplikuje neustávající vlna dezinformací o údajné "turbo rakovině".
Avatar
Fox News News source @foxnews.com · New York City 🇺🇸· 4w

#Type1Diabetes #mRNATherapy #DiabetesResearch

Link Preview
www.foxnews.com
Diabetes breakthrough approach could protect cells and prevent disease
Bain Brandon, a baby who was diagnosed with type 1 diabetes last year, explains his condition to his mom, Marlee. She was shocked when her 20-month-old son was able to explain parts of the disease.
Avatar
AP NEWS News source @apnews.com · New York City 🇺🇸· Feb 18

#Moderna #FluVaccine #mRNATechnology

Link Preview
apnews.com
Moderna says the FDA will consider its new flu shot after resolving a public dispute
WASHINGTON (AP) -- The Food and Drug Administration will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of-its-kind shot.
Avatar
Forbes News source @forbes.com · Jersey City, New Jersey 🇯🇪· Feb 12

#mRNA #vaccines #publichealth

Link Preview
www.forbes.com
HHS Casts Doubts On mRNA Products, But Funds Studies On Debunked Theories
After Moderna tested an investigational influenza shot in 41,000 people and published peer-reviewed results, the Food and Drug Administration isn't even considering Moderna's application for marketing authorization.
B
Bloomberg Business News source @bloomberg.com · New York City 🇺🇸· Feb 12

#FluVaccine #PublicHealth #mRNA

Link Preview
www.bloomberg.com
Moderna's Flu Vaccine Stalls at FDA Despite Need for Better Shot
Hi, it's Gerry and Bob in New York. Your chances of getting a powerful new weapon against the flu just got slimmer. More on that in a moment, but first .
Avatar
Yahoo News source @yahoo.com · Sunnyvale, California 🇺🇸· Feb 11

#Vaccines #mRNA #FDA

Link Preview
www.yahoo.com
Moderna says FDA refuses its application for new mRNA flu vaccine
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
Avatar
CBS News News source @cbsnews.com · New York 🇺🇸· Feb 11

#VaccinePolicy #mRNA #FDA

Link Preview
www.cbsnews.com
Moderna says FDA refuses its application for new mRNA flu vaccine
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
Avatar
CBS News News source @cbsnews.com · New York 🇺🇸· Feb 11

#Vaccines #mRNA #Healthcare

Link Preview
www.cbsnews.com
Moderna says FDA refuses its application for new mRNA flu vaccine
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
U
USA Today News source @usatoday.com · McLean, Virginia 🇺🇸· Feb 11

#Vaccines #mRNA #PublicHealth

Link Preview
www.usatoday.com
Moderna says FDA refuses to review its application for flu vaccine
The Food and Drug Administration has refused to review Moderna's application for its seasonal flu vaccine, the company announced Tuesday, Feb.
Avatar
CBS News News source @cbsnews.com · New York 🇺🇸· Feb 11

#Vaccine #mRNATechnology #FDA

Link Preview
www.cbsnews.com
Moderna says FDA refuses its application for new mRNA flu vaccine
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
Avatar
CBS News News source @cbsnews.com · New York 🇺🇸· Feb 11

#Vaccines #mRNA #FDA

Link Preview
www.cbsnews.com
Moderna says FDA refuses its application for new mRNA flu vaccine
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
Avatar
Yahoo News source @yahoo.com · Sunnyvale, California 🇺🇸· Feb 11

#Moderna #mRNAVaccine #FluVaccine

Link Preview
www.yahoo.com
Moderna says FDA refuses to review its new flu vaccine
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has refused to review Moderna's application for its seasonal flu vaccine, the company announced Tuesday, Feb.
Avatar
AP NEWS News source @apnews.com · New York City 🇺🇸· Feb 11

#Vaccines #mRNA #FDA

Link Preview
apnews.com
Moderna says FDA refuses its application for new mRNA flu vaccine
WASHINGTON (AP) -- The U. S. Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
Avatar
Yahoo! News source @ca.style.yahoo.com · Sunnyvale, California 🇺🇸· Feb 11

#Vakcíny #mRNA #FDA

Link Preview
ca.style.yahoo.com
Moderna says FDA refuses its application for new mRNA flu vaccine
WASHINGTON (AP) -- The U. S. Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
B
Bloomberg Business News source @bloomberg.com · New York City 🇺🇸· Jan 20

#CancerTreatment #PersonalizedMedicine #mRNATechnology

Link Preview
www.bloomberg.com
Moderna-Merck Skin Cancer Treatment Shows Long-Term Benefits
The new treatment uses messenger RNA technology to create a personalized therapy by analyzing the genetic sequence of each patient's tumor to train the immune system to spot and destroy the disease.
B
Bloomberg Business News source @bloomberg.com · New York City 🇺🇸· Jan 20

#CancerTreatment #PersonalizedMedicine #mRNATechnology

Link Preview
www.bloomberg.com
Moderna-Merck Skin Cancer Treatment Shows Long-Term Benefits
The new treatment uses messenger RNA technology to create a personalized therapy by analyzing the genetic sequence of each patient's tumor to train the immune system to spot and destroy the disease.
B
Bloomberg Business News source @bloomberg.com · New York City 🇺🇸· Jan 20

#CancerTreatment #PersonalizedMedicine #mRNATechnology

Link Preview
www.bloomberg.com
Moderna-Merck Skin Cancer Treatment Shows Long-Term Benefits
The new treatment uses messenger RNA technology to create a personalized therapy by analyzing the genetic sequence of each patient's tumor to train the immune system to spot and destroy the disease.